8-KEarnings & ResultsRegulation FDExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Financial Results (Jul 25, 2017)

Filed July 25, 2017For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on July 25, 2017, primarily to disclose its second-quarter 2017 financial results. The company issued a press release on July 25, 2017, which is attached as Exhibit 99.1, detailing its operational and financial performance for the quarter ended June 30, 2017. Investors should refer to this press release for specific financial metrics and operational updates. While the 8-K itself is a procedural filing, the attached press release contains the substantive information regarding HCA's performance. This includes key financial data such as revenue, earnings per share, and potentially guidance for the remainder of the year, all of which are critical for investors to assess the company's current health and future prospects. The filing signifies the company's commitment to timely disclosure of material information.

Key Highlights

  • 1HCA Healthcare announced its second-quarter 2017 financial results via a press release filed with the 8-K.
  • 2The filing occurred on July 25, 2017, and the press release is dated the same day.
  • 3Exhibit 99.1 contains the detailed press release with HCA's Q2 2017 performance.
  • 4The 8-K is a routine filing to publicly disseminate the Q2 earnings announcement.
  • 5Investors can find specific financial and operational data within the referenced press release.
  • 6The Chief Financial Officer, William B. Rutherford, signed the filing, indicating official company approval.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce HCA Healthcare's financial results for the second quarter ended June 30, 2017, by attaching the relevant press release as an exhibit.

The detailed financial results are located in the press release dated July 25, 2017, which is included as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself does not contain new strategic information; it serves to attach the press release announcing the Q2 2017 results. Any strategic commentary or guidance would be found within that attached press release (Exhibit 99.1).

The 8-K filing was signed by William B. Rutherford, Executive Vice President and Chief Financial Officer of HCA Healthcare, Inc.